-+ 0.00%
-+ 0.00%
-+ 0.00%

Adaptive Biotechnologies Q4 Earnings Assessment

Benzinga·02/05/2026 21:08:29
Listen to the news

The Q4 earnings report for Adaptive Biotechnologies (NASDAQ:ADPT) was released on Thursday, February 5, 2026 at 04:05 PM.

Here's what investors need to know about the latest announcement.

Earnings

Adaptive Biotechnologies beat estimated earnings by 52.63%, reporting an EPS of $-0.09 versus an estimate of $-0.19.

Revenue was up $24.22 million from the same period last year.

Analysis of Past Earnings

The company missed on EPS by $0.0 in the previous quarter, leading to a 11.54% drop share price change the next day.

Here's a look at Adaptive Biotechnologies's past performance:

Quarter Q3 2025 Q2 2025 Q1 2025 Q4 2024
EPS Estimate -0.15 -0.24 -0.31 -0.24
EPS Actual -0.15 -0.17 -0.20 -0.23
Revenue Estimate 66.00M 49.52M 42.13M 46.05M
Revenue Actual 60.20M 58.88M 52.40M 47.46M

To track all earnings releases for Adaptive Biotechnologies visit their earnings calendar here.

This article was generated by Benzinga's automated content engine and reviewed by an editor.